Xenotransplantation: the potential and the challenges.
Clinical use of xenotransplants is a potential way to provide care for a population of seriously ill patients and alleviate the demand for human organs. However, xenotransplantation also presents a spectrum of concerns, not only for individual patients but also for the public health, that must be discussed and dealt with in a science-based and public manner. Such discussions should take place on a national level and should include scientists, physicians, and policy makers from all countries in which the clinical use of xenografts is being considered.
Bloom
E T
ET
Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), Bethesda, Md., USA.
Moulton
A D
AD
McCoy
J
J
Chapman
L E
LE
Patterson
A P
AP
D000818:Animals; D003422:Critical Care; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control; D004992:Ethics, Medical; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control; D006291:Health Policy; D006801:Humans; D017053:Infection Control; D011634:Public Health; D013045:Species Specificity; D014183:Transplantation, Heterologous / Q000009:adverse effects / Q000379:methods / Q000451:nursing / Q000639:trends*; D014481:United States